Abstract
Purpose
Studies have reported a surge in the prevalence of obesity among various demographic groups including pregnant women in the U.S. Given the association between maternal obesity and risk of fetal macrosomia, we hypothesized that the incidence of fetal macrosomia will be on the rise in the U.S. We examined trends in fetal macrosomia and macrosomia phenotypes in the U.S. among singleton live births within the gestational age of 28–42 weeks inclusive.
Methods
This was a retrospective cohort study covering the period 1971–2017 using U.S. Natality Data files. We applied Joinpoint regression models to derive the average annual percentage change in the outcome. We measured incidence and trends of fetal macrosomia which was defined as birth weight ≥ 4000 g. We further subdivided macrosomia into its phenotypes as previously recommended: Grade 1 (4000–4499 g), Grade 2 (4500–4999 g) and Grade 3 (≥ 5000 g).
Results
A total of 147,331,305 singleton births over the entire study period of 47 years were analyzed. From a baseline incidence of 8.84%, the rate of fetal macrosomia declined to 8.07% by the end of the study representing a drop of 8.70% in relative terms. The greatest drop was among infants with Grade 3 macrosomia, the most severe and lethal phenotype. The most impactful factors were maternal age and gestational weight gain.
Conclusion
This study is the largest population-based study conducted regarding fetal macrosomia. The rate of fetal macrosomia declined over the previous 5 decades with the most substantial drop observed in the phenotype with the worst prognosis.
Similar content being viewed by others
References
Lu Y, Zhang J, Lu X, Xi W, Li Z (2011) Secular trends in macrosomia in southeast China, 1994–2005. BMC Public Health 11:1–9
Lahmann PH, Wills R, Coory M (2009) Trends in birth size and macrosomia in Queensland, Australia from 1988 to 2005. Paediatr Perinat Epidemiol 23:533–541
Shan X, Chen F, Wang W, Zhao J, Teng Y, Wu M et al (2014) Secular trends of low birthweight and macrosomia and related maternal factors in Beijing, China: a longitudinal trend analysis. BMC Pregnancy Childb 14:105
do Nascimento MI, Pereira DF, Lopata C, Oliveira CLF, de Moura AA, da Silva Mattos MJ et al (2018) Trends in the prevalence of live macrosomic newborns according to gestational age strata, in Brazil, 2001–2010, and 2012–2014. Revista Brasileira de Ginecologia e Obstetrícia 39:8
Chauhan SP, Grobman WA, Gherman RA, Chauhan VB, Chang G, Magann EF et al (2005) Suspicion and treatment of the macrosomic fetus: a review. Am J Obstet Gynecol 193:332–346
Lu GC, Rouse DJ, DuBard M, Cliver S, Kimberlin D, Hauth JC (2001) The effect of the increasing prevalence of maternal obesity on perinatal morbidity. Am J Obstet Gynecol 185:845–849
Hamilton BE, Martin JA, Osterman MJ, Curtin SC, Matthews TJ (2015) Births: final data for 2014. Natl Vital Stat Rep 64:1–64
Bamberg C, Hinkson L, Henrich W (2005) Prenatal detection and consequences of fetal macrosomia. Fetal Diagn Ther 33:143–148
Gu S, An X, Fang L, Zhang X, Zhang C, Wang J et al (2012) Risk factors and long-term health consequences of macrosomia: a prospective study in Jiangsu Province, China. J Biomed Res 26:235–240
Dai RX, He XJ, Hu CL (2019) The association between advanced maternal age and macrosomia: a meta-analysis. Child Obes 15(3):149–155. https://doi.org/10.1089/chi.2018.0258
Szostak-Wegierek D, Szamotulska K (2011) Fetal development and risk of cardiovascular diseases and diabetes type 2 in adult life. Med Wieku Rozwoj 15:203–215
CDC (2015) Updated estimates of neural tube defects prevented by mandatory folic acid fortification—United States, 1995–2011. Morb Mort Wkly Rep 64:1–5
Boulet SL, Salihu HM, Alexander GR (2006) Mode of delivery and the survival of macrosomic infants in the United States, 1995–1999. Birth 33:278–283
Boulet SL, Salihu HM, Alexander GR (2004) Mode of delivery and birth outcomes of macrosomic infants. Obstet Gynecol 24:622–629
Boulet SL, Alexander GR, Salihu HM (2005) Secular trends in cesarean delivery rates among macrosomic deliveries in the United States, 1989 to 2002. Perinatology 25:569–576
Boulet S, Alexander GR, Salihu HM, Pass M (2003) Macrosomic births in the United States: determinants, outcomes, and proposed grades of risk. Obstet Gynecol 188:1372–1377
Catov JM, Lee M, Roberts JM, Xu J, Simhan HN (2015) Race disparities and decreasing birth weight: are all babies getting smaller? Am J Epidemiol 183:15–23
American College of Obstetricians and Gynecologists (ACOG) (2016) Fetal macrosomia. Practice Bulletin No. 173. Obst Gynecol 128:e195–e209
Rhodes JC, Schoendorf KC, Parker JD (2003) Contribution of excess weight gain during pregnancy and macrosomia to the cesarean delivery rate, 1990–2000. Pediatrics 111:1181–1185
Salihu HM, Salinas A, August EM, Mogos MF, Weldeselasse H, Whiteman VE (2012) Small size for gestational age and the risk for infant mortality in the subsequent pregnancy. Ann Epidemiol 22:764–771
Buchanan TA, Kjos SL, Montoro MN, Wu PY, Madrilejo NG, Gonzalez M et al (1994) Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 17:275–283
American College of Obstetrics and Gynecology (2001) ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obst Gynecol 98(3):525–538
American College of Obstetrics and Gynecology (2013) Practice Bulletin No. 137: gestational diabetes mellitus. Obstet Gynecol 122(2 Pt 1):406–416
American College of Obstetrics and Gynecology (2017) Practice Bulletin No. 180: gestational diabetes mellitus. Obst Gynecol 130(1):e17–e37
American College of Obstetrics and Gynecology (2018) ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obst Gynecol 131(2):e49–e64
Mack LR, Tomich PG (2017) Gestational Diabetes: diagnosis, classification, and clinical care. Obstet Gynecol Clin N Am 44(2):207–217
American Diabetes Association (2019) 14. Management of diabetes in pregnancy: standards of medical care in diabetes—2019. Diabetes Care 42(Supplement 1):S165–S172
Berger H, Melamed N (2014) Timing of delivery in women with diabetes in pregnancy. Obst Med 7:8–16
Campbell S (2014) Fetal macrosomia: a problem in need of a policy (editorial). Ultrasounds Obst Gynecol 43:3–10
Xie K, Fu Z, Li H, Gu X, Cai Z, Xu P et al (2018) High folate intake contributes to risk of large for gestational age birth and obesity in male offspring. J Cell Physiol 233:9383–9389
Wang S, Ge X, Zhu B, Xuan Y, Huang K, Rutayisire E et al (2016) Maternal continuing folic acid supplementation after the first trimester of pregnancy increased the risk of large-for-gestational-age birth: a population-based birth cohort study. Nutrients 8:493
Najafian M, Cheraghi M (2012) Occurrence of fetal macrosomia rate and its maternal and neonatal complications: a 5-year cohort study. Int Scholarly Res Netw Obst Gynecol 2012:1–5
Funding
None.
Author information
Authors and Affiliations
Contributions
HMS: project development, manuscript writing. DD: data analysis, manuscript writing/editing, reviewing. LMK: manuscript writing/editing. KKY: manuscript writing/editing. SI: manuscript editing. AAS-M: manuscript writing/editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Study was considered by the Baylor College of Medicine IRB as exempt.
Ethical approval
The study was performed on de-identified secondary data. IRB approval from Baylor College of Medicine was obtained.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Salihu, H.M., Dongarwar, D., King, L.M. et al. Trends in the incidence of fetal macrosomia and its phenotypes in the United States, 1971–2017. Arch Gynecol Obstet 301, 415–426 (2020). https://doi.org/10.1007/s00404-019-05400-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-019-05400-9